IRD vs JCI · rev $2.9M vs P/E 44, rev $23.60B
Opus Genetics, Inc. (IRD) versus Johnson Controls International PLC (JCI) — a side-by-side from cached financials, not a winner call.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Latest reported IRD revenue for 2026-06-30 was $2.9M. Net income was -$73.6M. Revenue was up 35.0% from 2026-03-31 to 2026-06-30. IRD currently screens at market cap $35.7M.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
IRD currently screens at market cap $35.7M. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Not investment advice. Open the IRD and JCI stock pages for the full models.
Not investment advice.